2019
DOI: 10.3390/molecules24030624
|View full text |Cite
|
Sign up to set email alerts
|

Nanoformulation of a Novel Pyrano[2,3-c] Pyrazole Heterocyclic Compound AMDPC Exhibits Anti-Cancer Activity via Blocking the Cell Cycle through a P53-Independent Pathway

Abstract: Pyrano[2,3-c]pyrazole derivatives have been reported as exerting various biological activities. One compound with potential anti-tumor activity was screened out by MTT assay from series of dihydropyrazopyrazole derivatives we had synthesized before using a one-pot, four-component reaction, and was named as 6-amino-4-(2-hydroxyphenyl)-3-methyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile (hereinafter abbreviated as AMDPC). The IC50 of AMDPC against Bcap-37 breast cancer cells was 46.52 μg/mL. Then the hydrop… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
25
7

Year Published

2020
2020
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(33 citation statements)
references
References 17 publications
1
25
7
Order By: Relevance
“…The DL% of BBB4-G4K was very high, thus making possible a great bioactivity at a minimal dosage of the formulation. In fact, the DL% of BBB4-G4K NPs was 22.5-fold higher than that obtained recently by Sun et al [ 13 ], encapsulating the pyrazole derivative 6-amino-4-(2-hydroxyphenyl)-3-methyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile (AMDPC) in the commercial polymers poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) (PEG-PLGA), and obtaining micelles with DL% = 1.28. On the contrary, the EE% of BBB4-G4K was lower than that of the micelles [ 13 ].…”
Section: Resultscontrasting
confidence: 58%
See 2 more Smart Citations
“…The DL% of BBB4-G4K was very high, thus making possible a great bioactivity at a minimal dosage of the formulation. In fact, the DL% of BBB4-G4K NPs was 22.5-fold higher than that obtained recently by Sun et al [ 13 ], encapsulating the pyrazole derivative 6-amino-4-(2-hydroxyphenyl)-3-methyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile (AMDPC) in the commercial polymers poly(ethylene glycol) methyl ether-block-poly(lactide-co-glycolide) (PEG-PLGA), and obtaining micelles with DL% = 1.28. On the contrary, the EE% of BBB4-G4K was lower than that of the micelles [ 13 ].…”
Section: Resultscontrasting
confidence: 58%
“…Experiments to evaluate of the cytotoxicity of BBB4 on normal cells (human keratinocytes HaCaT) are currently undergoing. In any case, to have an idea of the cytotoxic effects of pyrazole-based compounds, we have herein reported ( Table 1 ) the cytotoxicity data found in the literature of some pyrazole derivatives on different human cancer cell lines such as A549 (lung cancer), HeLa (cervical cancer), MCF-7, and BCAP-37 (breast cancer) and a normal cell line (human embryonic kidney HEK-293) [ 13 , 24 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…15 In this context, pyranopyrazole systems have well been recognized for their potent biological activities including antimicrobial, 16 antioxidant, 17 antiviral 18 and antitumor. 19 Recently, we studied the reaction of the 6-amino-3-methyl-1,4-diphenyl-1,4-dihydropyrano-[2,3-c]pyrazole-5-carbonitrile (3) with some phosphorus halides. 20 Considering the above mentioned, we herein study the chemical reactivity of substrate 3 towards some other phosphorus amide and phosphorus esters in the presence of electrophilic reagents in a one-pot and three-components.…”
Section: Introductionmentioning
confidence: 99%
“…Dihydropyrano[2,3‐c]pyrazole 1 nucleus is a fruitful source of several medicinally important compounds because of its diverse bioactivities, such as anti‐inflammatory, [ 8,9 ] anticancer, [ 10–12 ] antioxidant, [ 13–15 ] anti‐cholinesterase, [ 16 ] analgesic, [ 9 ] antimicrobial activity, [ 17–20 ] and also act as human checkpoint kinase 1 (Chk1) inhibitor 5 (Figure 2). [ 21 ]…”
Section: Introductionmentioning
confidence: 99%